|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 5.110 CNY | -2.29% |
|
+2.20% | -0.20% |
| 07-16 | Jointown Pharmaceutical's Two Drugs Added to China's Essential Medicines List | MT |
| 06-11 | Jointown Pharma Issues 1 Billion Yuan in Asset-Backed Securities | MT |
| Market Cap | 25.48B 3.76B 3.29B 3.04B 2.79B 5.28B 362B 5.37B 36.26B 14.25B 177B 14.13B 13.82B 611B | P/E 2026 * |
10.9x | P/E 2027 * | 10.1x |
|---|---|---|---|---|---|
| Enterprise Value | 21.16B 3.12B 2.73B 2.53B 2.32B 4.39B 301B 4.46B 30.11B 11.83B 147B 11.73B 11.47B 507B | EV / Sales 2026 * |
0.12x | EV / Sales 2027 * | 0.11x |
| Free-Float |
43.03% | Yield 2026 * |
4.09% | Yield 2027 * | 4.36% |
| 1 day | -2.29% | ||
| 1 week | +2.20% | ||
| Current month | +8.96% | ||
| 1 month | +6.68% | ||
| 3 months | -4.31% | ||
| 6 months | -2.67% | ||
| Current year | -0.20% |
| 1 week | 4.98 |  | 5.28 |
| 1 month | 4.48 | | 5.28 |
| Current year | 4.48 | | 5.84 |
| 1 year | 4.48 | | 5.84 |
| 3 years | 4.35 | | 6.94 |
| 5 years | 3.97 | | 6.94 |
| 10 years | 3.97 | | 8.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Wei He
CEO | Chief Executive Officer | 40 | 22/04/2022 |
Xiao Yi Xia
DFI | Director of Finance/CFO | 48 | 14/11/2023 |
Xi Zhang
IRC | Investor Relations Contact | - | 22/04/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Zhao Nian Liu
BRD | Director/Board Member | 66 | 15/11/2008 |
Deng Pan Liu
BRD | Director/Board Member | 48 | 04/11/2020 |
Yi Hua Gong
BRD | Director/Board Member | 48 | 30/06/2012 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.29% | +2.20% | -5.02% | -5.83% | 3.85B | |
| +1.62% | +6.10% | +20.39% | +107.72% | 98.5B | |
| +1.67% | -1.43% | +45.76% | +148.67% | 53.57B | |
| -0.34% | +2.09% | +6.55% | +280.52% | 23.68B | |
| -2.52% | +3.36% | -13.53% | -21.24% | 8.45B | |
| -5.82% | +4.48% | -29.13% | -32.92% | 8.27B | |
| -1.35% | +5.46% | -5.13% | -25.07% | 7.09B | |
| +2.44% | +0.89% | +25.25% | +34.78% | 6.18B | |
| +1.10% | +3.00% | +0.06% | +26.02% | 5.45B | |
| +1.62% | +5.01% | +18.44% | +23.26% | 3.53B | |
| Average | -0.42% | +1.86% | +6.36% | +53.59% | 21.86B | |
| Weighted average by Cap. | +0.83% | +2.21% | +20.25% | +114.39% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 170B 25.07B 21.91B 20.26B 18.59B 35.19B 2,415B 35.8B 242B 94.93B 1,179B 94.13B 92.07B 4,072B | 180B 26.55B 23.2B 21.46B 19.69B 37.27B 2,558B 37.92B 256B 101B 1,249B 99.69B 97.5B 4,313B |
| Net income | 2.36B 348M 304M 281M 258M 488M 33.51B 497M 3.35B 1.32B 16.36B 1.31B 1.28B 56.5B | 2.56B 378M 330M 305M 280M 530M 36.39B 539M 3.64B 1.43B 17.77B 1.42B 1.39B 61.36B |
| Net Debt | -4.32B -638M -558M -516M -473M -896M -61.46B -911M -6.15B -2.42B -30.01B -2.4B -2.34B -104B | -5.04B -744M -651M -602M -552M -1.05B -71.74B -1.06B -7.18B -2.82B -35.03B -2.8B -2.73B -121B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | CN¥5.110 | -2.29% | 47,920,070 |
| 16/07/26 | CN¥5.230 | +1.36% | 57,762,090 |
| 15/07/26 | CN¥5.160 | -0.96% | 53,342,812 |
| 14/07/26 | CN¥5.210 | +2.96% | 77,010,061 |
| 13/07/26 | CN¥5.060 | +1.00% | 46,963,570 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- 600998 Stock
Choose MarketScreener Select your edition
All financial news and data tailored to specific country editions
